Drug Shortage Report for SODIUM NITROPRUSSIDE FOR INJECTION
| Report ID | 141744 |
| Drug Identification Number | 02479109 |
| Brand name | SODIUM NITROPRUSSIDE FOR INJECTION |
| Common or Proper name | Sodium Nitroprusside |
| Company Name | MARCAN PHARMACEUTICALS INC |
| Market Status | MARKETED |
| Active Ingredient(s) | SODIUM NITROPRUSSIDE |
| Strength(s) | 25MG |
| Dosage form(s) | SOLUTION |
| Route of administration | INTRAVENOUS INTRAVENOUS |
| Packaging size | 1 Vial |
| ATC code | C02DD |
| ATC description | ARTERIOLARSMOOTH MUSCLE, AGENTS ACTING ON |
| Reason for shortage | Disruption of the manufacture of the drug. |
| Anticipated start date | 2021-06-20 |
| Actual start date | 2021-06-20 |
| Estimated end date | 2022-01-31 |
| Actual end date | 2022-01-07 |
| Shortage status | Resolved |
| Updated date | 2022-01-08 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 2 GURDWARA RD., SUITE 112 OTTAWA, ONTARIO CANADA K2E 1A2 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v6 | 2022-01-08 | French | Compare |
| v5 | 2022-01-08 | English | Compare |
| v4 | 2022-01-04 | French | Compare |
| v3 | 2022-01-04 | English | Compare |
| v2 | 2021-07-02 | French | Compare |
| v1 | 2021-07-02 | English | Compare |
Showing 1 to 6 of 6